Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,019	$ 3,498
Accounts receivable, net of allowance for credit loss of $26 and $0, respectively	6,206	4,983
Other current assets	1,941	1,841
Total current assets	10,166	10,322
Property and equipment, net	1,126	790
Operating lease right of use assets	1,635	1,864
Other long-term assets	45	45
Total assets	12,972	13,021
Current liabilities:
Accounts payable	1,761	1,544
Accrued salary and bonus	1,243	1,969
Other accrued expenses	8,582	8,201
Note payable at fair value, current	6,784	5,100
Current liabilities of discontinued operations	660	660
Total current liabilities	19,030	17,474
Operating lease liabilities, net of current portion	1,286	1,472
Note payable at fair value		4,243
Other long-term liabilities	5,146	4,968
Total liabilities	25,462	28,157
Commitments and contingencies (Note 8)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding	46,536	46,536
Stockholders’ deficit:
Common stock, $.01 par value; 100,000,000 shares authorized; 4,487,157 and 4,447,489 shares issued, respectively; 4,376,398 and 4,351,445 shares outstanding, respectively	406	405
Additional paid-in capital	188,277	188,146
Accumulated deficit	(245,685)	(248,215)
Treasury stock, at cost (110,759 and 96,044 shares, respectively)	(2,024)	(2,008)
Total stockholders’ deficit	(59,026)	(61,672)
Total liabilities and stockholders’ deficit	(33,564)	(33,515)
Total liabilities, preferred stock and stockholders’ deficit	$ 12,972	$ 13,021